Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.475    0.00 (0.00%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £2.15m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Director/PDMR Shareholding

18 Oct 2005 12:06

Acquisition of shares by CEO Oxford, UK, 18 October 2005 The Board of Physiomics plc (AIM:PYC), a Europeansystems biology simulation company, was informed on 17 October that Dr JohnSavin, CEO, has paid, with the agreement of the Board, in cash for 54,688shares at 2p per share. These shares were issued in December 2004 in respect ofa small overcharge of third party flotation costs.Dr Savin's shareholding has increased to 604,688 ordinary shares of 0.04pcomprising 0.26% of the Company's issued share capital. --ENDS- For further information please contact: Physiomics plcMr David Evans (Chairman) Tel: 07740 084452Dr John Savin (CEO) Tel: 01865 784981 Northbank Communications Tel: 020 7886 8150Emma Palmer (financial enquiries)Fiona Brown/Rowan Minnion (media enquiries)Notes to EditorsPhysiomics plcPhysiomics plc (AIM:PYC) is a systems biology company applying computer-basedsimulations of cell behaviour in drug development, aimed at reducing the highcost and attrition rates of clinical trials. As 80-90 per cent of all clinicaldrug candidates fail to reach the market, estimates show even a ten per cent.overall improvement in success rates could reduce the cost of one drug'sdevelopment by up to $242 million, from the current estimate of around $800million.Physiomics is currently focused on optimising the design of cancer clinicaltrials as a service to major pharmaceutical companies. In addition, it hassecured an option to in-license two innovative molecules in the cancer areafrom Cronos therapeutics.Physiomics has a major collaboration with BayerTechnology Services GmbH to develop globally clinical response predictionservices using both companies' proprietary technologies and mathematical cellmodels, including the SystemCell‚® technology developed by Physiomics. In June2005, Physiomics became is a distributor of Bayer's PK-Sim‚® product forunderstanding the way pharmaceuticals are distributed round the body.Physiomics, based in Oxford, UK, was founded in 2001, and floated on AIM in2004.For further information, please visit www.physiomics-plc.comSystemCell is a registered trademark of Physiomics plcPHYSIOMICS PLC
Date   Source Headline
14th Jul 20257:00 amRNSTrading Update
10th Jul 20257:00 amRNSPlatform Implementation and Partnership Expansion
1st Jul 20257:00 amRNSContract Award
16th Jun 20257:00 amRNSNew Head of Biometrics and Two Contracts Awarded
29th May 20257:00 amRNSPhysiomics Awarded Contract Extension
9th May 20257:00 amRNSContract Award with New UK Client
7th May 20254:45 pmRNSAIM Rule 17 and Schedule 2(g) Update
17th Apr 20257:00 amRNS-RPhysiomics Awarded New Contract
16th Apr 20257:00 amRNS-RPublication of Peer Reviewed Article
15th Apr 20257:00 amRNS-RContract Award
17th Mar 20257:00 amRNSContract Award with new client
13th Mar 20257:00 amRNS-RIMC Presentation on Company Website
6th Mar 20257:00 amRNSInterim Results
28th Feb 20257:00 amRNSNotice of Results and Investor Presentation
20th Feb 202512:00 pmRNSHolding(s) in Company
17th Feb 20251:00 pmRNSResult of WRAP Retail Offer
13th Feb 20257:01 amRNSWRAP Retail Offer for up to £70,000
13th Feb 20257:00 amRNSCompletion of Placing & WRAP Retail Offer Launch
30th Jan 20257:00 amRNSPublication of Peer Reviewed Article
30th Jan 20257:00 amRNSTrading Update
28th Jan 202511:30 amRNSHolding(s) in Company
10th Jan 20257:00 amRNS-RPublication of Peer Reviewed Article
12th Dec 202412:00 pmRNSContract Award
5th Dec 20247:00 amRNSContract Award
19th Nov 20244:50 pmRNSResult of AGM
8th Nov 20247:00 amRNSDirector Dealing
4th Nov 20247:00 amRNSSenior Management Announcement
17th Oct 20247:00 amRNSNotice of AGM
17th Oct 20247:00 amRNSContract Award
15th Oct 202411:57 amRNS-RIMC Presentation on Company Website - Amendment
15th Oct 202411:30 amRNS-RIMC Presentation on Board Changes
2nd Oct 20247:00 amRNS-RNew Services Launch and Website Update
27th Sep 20247:00 amRNSAnnual Financial Report
19th Sep 20247:00 amRNSNotice of Results and Investor Presentation
17th Sep 20247:00 amRNSContract Award
5th Jul 20247:00 amRNSResult of WRAP Retail Offer
3rd Jul 20247:00 amRNSWRAP Retail Offer for up to £25,000
3rd Jul 20247:00 amRNSCompletion of Placing & WRAP Retail Offer Launch
13th Jun 20247:00 amRNSContract Award
7th Jun 20247:00 amRNSContract Award
31st May 20242:00 pmRNSBoard Change
3rd May 20247:00 amRNSTrading Update
21st Mar 20247:00 amRNSIMC Presentation on Company Website
18th Mar 20247:00 amRNSContract Award
7th Mar 20247:00 amRNSInterim Results
1st Mar 20243:00 pmRNSNotice of Results and Investor Presentation
19th Feb 20247:00 amRNSContract Award
6th Feb 20247:00 amRNSOptions Award
5th Feb 20247:00 amRNSContract Award
2nd Feb 20247:00 amRNSIMC Presentation on Company Website

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.